| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM199108013250505 |
| P698 | PubMed publication ID | 1647496 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | headache | Q86 |
| P304 | page(s) | 322-326 | |
| P577 | publication date | 1991-08-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Treatment of Acute Cluster Headache with Sumatriptan | |
| P478 | volume | 325 |
| Q37374062 | A simple one-pot 2-step N-1-alkylation of indoles with α-iminoketones toward the expeditious 3-step synthesis of N-1-quinoxaline-indoles |
| Q42917905 | Acute and preventive treatment of cluster headache and other trigeminal autonomic cephalgias |
| Q35692997 | Acute, subacute, and chronic headache |
| Q48157389 | Advanced technologies and novel neurostimulation targets in trigeminal autonomic cephalalgias |
| Q38907735 | Advances in the understanding of cluster headache |
| Q42281088 | Adverse reactions attributed to sumatriptan. A postmarketing study in general practice |
| Q28376488 | Alteration in nature of cluster headache during subcutaneous administration of sumatriptan |
| Q33957309 | Bi-allelic and tri-allelic 5-HTTLPR polymorphisms and triptan non-response in cluster headache |
| Q34307161 | Buspirone, but not sumatriptan, induces miosis in humans: Relevance for a serotoninergic pupil control* |
| Q41974492 | Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. |
| Q36053732 | Changes in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptan |
| Q35884305 | Chronic cluster headache: new and emerging treatment options |
| Q35229878 | Clinical effects and mechanism of action of sumatriptan in migraine |
| Q73238904 | Cluster Headache |
| Q21202910 | Cluster headache |
| Q24605568 | Cluster headache |
| Q87919157 | Cluster headache |
| Q79095631 | Cluster headache and cluster variants |
| Q36422265 | Cluster headache and the heart. |
| Q42785032 | Cluster headache in primary care: unmissable, underdiagnosed and undertreated |
| Q47968905 | Cluster headache management and beyond |
| Q35072599 | Cluster headache or giant cell arteritis? |
| Q36783082 | Cluster headache syndrome. Ways to abort or ward off attacks |
| Q37834036 | Cluster headache--acute and prophylactic therapy |
| Q34502400 | Cluster headache: a case-based review of diagnostic and treatment approaches |
| Q34492603 | Cluster headache: aetiology, diagnosis and management |
| Q35199249 | Cluster headache: clinical features and therapeutic options |
| Q38114954 | Cluster headache: conventional pharmacological management |
| Q81469618 | Cluster headache: diagnosis and treatment |
| Q81473901 | Cluster headache: diagnosis and treatment |
| Q34413883 | Cluster headache: focus on emerging therapies |
| Q48913187 | Cluster headache: from vascular theories to brain therapy |
| Q33833914 | Cluster headache: new perspectives |
| Q34650944 | Cluster headache: pathogenesis, diagnosis, and management. |
| Q37406956 | Cluster headache: pharmacological treatment and neurostimulation |
| Q38681567 | Cluster headache: present and future therapy |
| Q48418655 | Cluster headaches--central or peripheral in origin? |
| Q33438958 | Costs of hypothalamic stimulation in chronic drug-resistant cluster headache: preliminary data |
| Q37610198 | Current and emerging treatment options for migraine and other primary headache disorders |
| Q33158679 | Deep brain stimulation in trigeminal autonomic cephalalgias |
| Q24651176 | Diagnosis and management of the primary headache disorders in the emergency department setting |
| Q47227416 | Diagnosis, pathophysiology, and management of cluster headache |
| Q34065402 | Double-blind placebo-controlled trial of lithium in episodic cluster headache |
| Q46141274 | Early responses in randomized clinical trials of triptans in acute migraine treatment. Are they clinically relevant? A comment |
| Q46008523 | Effective headache management. Strategies to help patients gain control over pain. |
| Q46609582 | Effectiveness of zolmitriptan nasal spray for the acute treatment of cluster headache: study 1. |
| Q33443722 | Efficacy of oxygen inhalation in sumatriptan refractory "high altitude" cluster headache attacks |
| Q41736691 | Emergency department evaluation of headache |
| Q42413623 | Epigenetics in primary headaches: a new avenue for research |
| Q48799289 | Episodic cluster headache in a community: clinical features and treatment. |
| Q34466164 | Ethical considerations in cluster headache research |
| Q30667188 | Etiology and pathogenesis of cluster headache |
| Q40415807 | Evaluation of guideline-adherent treatment in cluster headache |
| Q37409623 | Evidence base for the medical treatments used in cluster headache |
| Q26774849 | Evidence-based treatments for cluster headache |
| Q38350393 | Exacerbation of SUNCT and SUNA syndromes during intravenous dihydroergotamine treatment: A case series |
| Q45164392 | Frovatriptan for the treatment of cluster headaches |
| Q39338226 | G protein beta3 polymorphism and triptan response in cluster headache |
| Q37738286 | Genetics of cluster headache |
| Q45078754 | Headache attacks with ipsilateral autonomic symptoms |
| Q40868603 | Headache to worry about. |
| Q40604605 | Headaches. |
| Q51698198 | Hyperbaric oxygen treatment of active cluster headache: a double-blind placebo-controlled cross-over study. |
| Q40288155 | Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey |
| Q30466790 | Italian guidelines for primary headaches: 2012 revised version |
| Q36516759 | Long-term use of daily sumatriptan injections in severe drug-resistant chronic cluster headache |
| Q55918731 | Management of Cluster Headache |
| Q82606049 | Management of chronic cluster headache |
| Q35194332 | Management of trigeminal autonomic cephalgias and hemicrania continua |
| Q91664744 | Managing cluster headache |
| Q74452893 | Migraine |
| Q39471681 | Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience |
| Q51011775 | Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. |
| Q34466184 | Misdiagnosis of cluster headache |
| Q44251145 | Naratriptan in the preventive treatment of cluster headache |
| Q43989445 | Naratriptan in the prophylaxis of cluster headache |
| Q43572330 | Naratriptan prophylactic treatment in cluster headache |
| Q34218319 | Neuroimaging in headache |
| Q26752211 | Neurostimulation in the treatment of primary headaches |
| Q34494441 | New therapeutic approaches for the prevention and treatment of migraine |
| Q34566291 | New treatments in cluster headache |
| Q38387932 | Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study |
| Q47258557 | Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study |
| Q46661667 | Occipital neuroma triggered cluster headache responding to greater occipital nerve blockade |
| Q45192198 | Octreotide is not effective in the acute treatment of migraine |
| Q37989840 | Oral triptans in the preventive management of cluster headache |
| Q38203868 | Oxygen treatment of cluster headache: a review |
| Q36978875 | Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. a comment |
| Q37553382 | Pathophysiology of trigeminal autonomic cephalalgias |
| Q34388888 | Patient satisfaction with conventional, complementary, and alternative treatment for cluster headache in a Norwegian cohort |
| Q43964370 | Persistence of attacks of cluster headache after trigeminal nerve root section |
| Q93042840 | Pharmacotherapy for Cluster Headache |
| Q34122086 | Pharmacotherapy of cluster headache |
| Q38441520 | Pharmacotherapy options for cluster headache |
| Q89683632 | Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment |
| Q46577599 | Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial |
| Q35209633 | Placebo response in cluster headache trials: a review |
| Q39433222 | Randomised trial on episodic cluster headache with an angiotensin II receptor blocker |
| Q40698410 | Recent advances in the acute management of migraine and cluster headaches |
| Q33976138 | Recognition and treatment of cluster headache in the emergency department |
| Q35697308 | Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012 |
| Q31992283 | Relief of cluster headache and cranial neuralgias. Promising prophylactic and symptomatic treatments |
| Q39366322 | Remission of atypical and refractory cluster headache after topiramate administration |
| Q46673684 | Resident and fellow section. Expert opinion: trigeminal autonomic cephalgia post transsphenoidal surgery |
| Q33734855 | Secondary cluster headache responsive to sumatriptan |
| Q37832687 | Serotonergic agents in the management of cluster headache |
| Q41371800 | Serotonin 1D (5-HT1D) agonists and other agents in acute migraine |
| Q50897742 | Serotonin metabolism in cluster headache. |
| Q37875788 | Sex hormones and primary headaches other than migraine. |
| Q35738111 | Sinus headache: a clinical conundrum |
| Q38848563 | Sphenopalatine Ganglion (SPG): Stimulation Mechanism, Safety, and Efficacy |
| Q38208825 | Sphenopalatine ganglion stimulation for the treatment of cluster headache |
| Q37047300 | Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study |
| Q43778285 | Sumatriptan in the treatment of cluster headache |
| Q57025129 | Sumatriptan is a Potent Vasoconstrictor of Human Dural Arteries Via a 5-HT1-Like Receptor |
| Q37862232 | Sumatriptan needle-free subcutaneous (Sumavel(®) DosePro™) approved for the acute treatment of migraine, with or without aura, and cluster headaches |
| Q38046616 | Sumatriptan succinate : pharmacokinetics of different formulations in clinical practice |
| Q33755782 | Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal |
| Q39485720 | Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache |
| Q35329290 | Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache |
| Q35229339 | Sumatriptan: A Selective 5-Hydroxytryptamine Receptor Agonist for the Acute Treatment of Migraine |
| Q38190436 | Supraorbital and supratrochlear stimulation for trigeminal autonomic cephalalgias |
| Q39498342 | The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache |
| Q26786375 | The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias |
| Q51383579 | The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache. |
| Q33926144 | The misdiagnosis of cluster headache: a nonclinic, population-based, Internet survey |
| Q33535327 | The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation |
| Q38148805 | The usual treatment of trigeminal autonomic cephalalgias |
| Q43161563 | Tired all the time |
| Q35082037 | Topical agents in the treatment of cluster headache |
| Q34185073 | Treatment and management of cluster headache |
| Q34650552 | Treatment and prophylaxis for cluster headaches and other trigeminal autonomic headaches. Revised recommendations of the German Migraine and Headache Society |
| Q55389957 | Treatment of Cluster Headache. |
| Q38216901 | Trigeminal autonomic cephalalgias |
| Q36873355 | Trigeminal autonomic cephalalgias. Part 1: cluster headache |
| Q36758782 | Trigeminal autonomic cephalalgias: diagnosis and treatment |
| Q36641524 | Trigeminal-autonomic headaches in daily clinical practice |
| Q24201161 | Triptans for acute cluster headache |
| Q24235872 | Triptans for acute cluster headache |
| Q24241164 | Triptans for acute cluster headache |
| Q34548435 | Triptans: do they differ? |
| Q34589174 | Update on the therapy of the trigeminal autonomic cephalalgias |
| Q30584718 | Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data |
| Q44765505 | Vasoreactivity of the intracranial internal carotid artery |
Search more.